The FluMist vaccine, manufactured by AstraZeneca, had previously been approved back in 2003 to be given by health care ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.

(Reuters) -The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind. FluMist is the first ...

HUNTINGTON, W.Va. (WSAZ) - A new flu vaccine is on its way, and this one can be administered at home. The FDA has approved AstraZeneca’s FluMist Nasal Spray to be used outside a healthcare setting.

Here's the information you need about the at-home flu vaccine. According to the FDA ... FluMist was produced by the AstraZeneca company. The FDA stated in a release on Friday, "FluMist is approved ...

AstraZeneca expects this option to be available ... It is possible that we will see an increase in FluMist’s US flu vaccine patient share, given the convenient route of administration and ...

AstraZeneca made headlines on Tuesday as it initiated the global withdrawal of its COVID-19 vaccine. This decision comes weeks after the pharmaceutical giant acknowledged the vaccine's potential ...

More than 60% of the world's population - 4.8 billion people - have received at least one dose of coronavirus vaccine. There are different approved types and brands available and all have ...

The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007 ... FluMist is officially the first ...

has approved the first nasal spray flu vaccine which can be administered by the patient or a caregiver. FluMist, produced by European pharmaceutical company and Covid vaccine-maker AstraZeneca ...